<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="85798">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02078050</url>
  </required_header>
  <id_info>
    <org_study_id>2013-A00638-37</org_study_id>
    <nct_id>NCT02078050</nct_id>
  </id_info>
  <brief_title>Volontary Inspiratory Muscles Measures Compared With Phrenic Nerves Magnetic Stimulations Measures</brief_title>
  <official_title>Volontary Inspiratory Muscles Measures Compared With Phrenic Nerves Magnetic Stimulations Measures</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre d'Investigation Clinique et Technologique 805</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre d'Investigation Clinique et Technologique 805</source>
  <oversight_info>
    <authority>France: Comité consultatif sur le traitement de l'information en matière de recherche dans le domaine de la santé</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Respiratory failure is the main death cause in neuromuscular diseases. Non-invasive and
      volitional measures of inspiratory muscles strength include the nasal pressure with an
      occluded nostril (Psnip) and the maximal inspiratory pressure (PImax). Unfortunately,
      volitional maneuvers depend of  patient effort. The aim of this research is to validate a
      non-invasive and non-volitional technique to evaluate diaphragm strength at neuromuscular
      diseases patients. The methodology consists to add to PImax and Psnip measures  5  phrenic
      nerves  magnetical stimulation maneuvers (Pstim).Stimulations will be realize at 3
      inspiratory pression levels (0, -1 cm H2O and -5 cm H2O).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2013</start_date>
  <completion_date type="Anticipated">April 2015</completion_date>
  <primary_completion_date type="Anticipated">April 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Intervention Model: Single Group Assignment, Masking: Open Label</study_design>
  <primary_outcome>
    <measure>Magnetic stimulation pressure measure (Pstim), according to 3 conditions : Pstime, Pstim-5 and Pstim-1 (measured in cmH20).  The condition which is most correlated with maximal  inspiratory pressure (Pimax or Psnip) is selected.</measure>
    <time_frame>10 minutes</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Neuromuscular Diseases</condition>
  <condition>Respiratory Failure</condition>
  <arm_group>
    <arm_group_label>Phrenic nerves magnetic stimulations</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Phrenic nerves magnetic stimulations</intervention_name>
    <arm_group_label>Phrenic nerves magnetic stimulations</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 years old and more men or women

          -  neuromuscular diseases

          -  Pimax and Snip evaluation Indication

        Exclusion Criteria:

          -  pregnant women

          -  Usual contre-indications for nuclear magnetic resonance
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Frédéric Lofaso, Pr</last_name>
    <phone>+3310147107941</phone>
    <email>f.lofaso@rpc.aphp.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hopital R. Poincaré</name>
      <address>
        <city>Garches</city>
        <zip>92380</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frédéric Lofaso, Pr</last_name>
      <phone>+3310147107941</phone>
      <email>f.lofaso@rpc.aphp.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 3, 2014</lastchanged_date>
  <firstreceived_date>December 20, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Respiratory Aspiration</mesh_term>
    <mesh_term>Neuromuscular Diseases</mesh_term>
    <mesh_term>Respiratory Insufficiency</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
